FSTL1 and hydrops fetalis: In humans, circulating concentrations of FSTL1 increase during cardiac and vascular diseases, such as HF [9, 35], HF with preserved ejection fraction (HFpEF) [15], acute coronary syndrome (ACS) [36], and chronic obstructive pulmonary disease [37].